GALILEO CONSULTING GROUP, INC. for CELLECTAR INC
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
-- Issues related to a better and more productive Food and Drug Administration, including the language in the 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act (introduced in the Senate as S 717).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL RATHBUN | — |
Medicare/Medicaid MMM
-- HR 3200: America's Affordable Health Choices Act of 2009 and its previous discussion draft - Section 1142, delete section on extending reimbursement for therapeutic radiopharmaceutical based on hospital specific cost-to-charge ratio. -- Senate health care reform discussion papers - Delete language on extending reimbursement for therapeutic radiopharmaceutical based on hospital specific cost-to-charge ratio.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL RATHBUN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.